作者:
Tapia, Milagritos D. [1]
;
Findlow, Helen [2]
;
Idoko, Olubukola T. [3]
;
Preziosi, Marie-Pierre [4]
;
Kulkarni, Prasad S. [5]
;
Enwere, Godwin C. [6]
;
Elie, Cheryl [7]
;
Parulekar, Varsha [8]
;
Sow, Samba O. [9]
;
Haidara, Fadima Cheick [10]
;
Diallo, Fatoumata ;
Doumbia, Moussa ;
Akinsola, Adebayo K. ;
Adegbola, Richard A. ;
Kampmann, Beate ;
Chaumont, Julie ;
Martellet, Lionel ;
Marchetti, Elisa ;
Viviani, Simonetta ;
Tang, Yuxiao ;
Plikaytis, Brian D. ;
LaForce, F. Marc ;
Carlone, George ;
Borrow, Ray
作者单位:
Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England
[1]
Ctr Dis Control & Prevent, Atlanta, GA USA
[2]
Minist Sante, Ctr Dev Vaccins, Bamako, Mali
[3]
Univ Maryland, Ctr Vaccine Dev, Sch Med, Dept Pediat, Baltimore, MD 21201 USA
[4]
GlaxoSmithKline Vaccines, Wavre, Belgium
[5]
Serum Inst India Ltd, Pune, Maharashtra, India
[6]
DiagnoSearch Life Sci, Bombay, Maharashtra, India
[7]
PATH, Meningitis Vaccine Project, Ferney Voltaire, France
[8]
PATH, Meningitis Vaccine Project, Seattle, WA USA
[9]
MRC Unit, Vaccines & Immun Theme, Basse, Gambia
[10]
发布时间
2017-04-06